Dr. Stephen Lev Seliger, MD

Dr. Seliger practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Seliger's NPI, 1447290671, was assigned on June 7, 2006. Dr. Seliger graduated from New York University Medical College - Nlg in 1996. Dr. Seliger holds Maryland license D62374.

Dr. Seliger's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Seliger's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. The medical group on file is University of Maryland Medical Center Gastroenterology and Hepatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seliger practices. Vendor and product names are available with a free account.

Nephrology is Dr. Seliger's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Seliger is licensed in Maryland.

CMS data shows 253 Medicare services from Dr. Seliger across 4 procedure codes in 2024, for 104 Medicare patients. Medicare paid $13,967 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 104 Medicare patients who saw Dr. Seliger in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Seliger's median patient age at 74, with 54% women.

In 2024, Dr. Seliger wrote 185 Medicare Part D claims for 39 patients. 81% of them were for generic drugs. CMS names the drug for 85 of them, across 4 drugs with 11 or more claims each, at $20,730 in total drug cost. In 2019, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Seliger for performance year 2024, reported as part of a group. Dr. Seliger accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 139 papers to Dr. Seliger, published from 2005 to 2025. 2019 was the busiest year, with 13. The most frequent topics are Renal Insufficiency, Chronic, Glomerular Filtration Rate and Heart Failure. Dr. Seliger has published most often in Clin J Am Soc Nephrol. Dr. Seliger's most frequent co-authors are Bryan R. Kestenbaum, Alan S. Go, MD and James P. Lash.

Dmand AI links Dr. Seliger to 6 clinical trials, 2 of them phase 3 studies. Conditions studied include Polycystic Kidney, Autosomal Dominant, Polycystic Kidney Diseases and Renal Insufficiency, Chronic. University of Maryland, Baltimore sponsors the most, 2. Open Payments lists research payments to Dr. Seliger that name 1 trial.

CMS Open Payments shows 6 general payments to Dr. Seliger from 2 drug and device companies from 2016 to 2019. Travel and lodging make up the largest share, 51% of the total. Abbvie Inc. paid the most, $306. It also lists 21 research payments totaling $29,465 from 2016 to 2021, naming 1 clinical trial.

Dr. Seliger graduated from New York University Medical College - Nlg in 1996.